Delivery Order SPE2DB20D2104-SPE2DB23FS60V
- Not listed
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 mL pen in 0.5 mL dosage. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,058.83 and a period of performance through April 26, 2024. This award is not set aside for any specific business classification. Amerisourcebergen Drug Corp is a major...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens, valued at $1,387.68. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies,...
- This federal contract award is for the delivery of the drug Mounjaro (7.5 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,574.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has an ultimate completion date of May 18, 2023. This contract does not have a set-aside designation, indicating it...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract, valued at $2,587.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,742.98 and an ultimate completion date of May 7, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 2.5 mg/0.5 ml pen with a total ceiling value of $1,052.00. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $8,424.72 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the...
- This federal contract award is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The award, valued at $1,052.00, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with an ultimate completion date of December 14, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $4,359.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,249,563 units of the medication Mounjaro 2.5 mg/0.5 ml pen, with a completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,581.45 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS60VDelivery Order
This federal contract award is for the delivery of 4,560,259,125 units of the drug Mounjaro 2.5 mg/0.5 ml pen. The contract, valued at $1,578.00, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract type is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 15, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/14/23 |